Samenvatting
The effects of Lorazepam and Bromazepam, an actual driving and psychomotor performance in anxious out-patients are investigated. Results suggest that performance impairment observed in a laboratory test after subchronic administration of 1.0 my of Lorazepam three times a day to anxious patients does not necessarily result in impaired driving performance; but further investigation is needed. Bromazepam-treated patients showed no signs of performance impairment at all.